PDTC reduced proliferation in ADPKD cells but did not consistently alter NF-κB activation, suggesting that other signalling pathways are likely to be involved in its ability to attenuate renal cyst growth in vivo. The gene discussed is NFKB1; the disease is autosomal dominant polycystic kidney disease.